As their use expands, patients and clinicians naturally question potential adverse effects, including whether these medications increase the risk of blood clots
Now, a new GLP-1 map shows a state-by-state breakdown of how many people are using these medications
DANGEROUS 'GRAY-MARKET' WEIGHT-LOSS DRUGS FLOODING US AS EXPERTS WARN OF RISKS In the case review, presented this week at the 38th Annual Congress of the European Association of Nuclear Medicine in Barcelona, Spain, researchers analyzed cancer scans of patients who were taking GLP-1 medications, according to a press release
If you are interested in learning more about medical weight loss options, including semaglutide GLP-1 and Zepbound, please schedule a consultation with Dr
The smaller cohort participants were matched to their nearest demographic neighbor before analysis to improve comparisons between cases and controls